EPISODE · Jul 16, 2025 · 34 MIN
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
from Citeline Podcasts · host Norstella
The latest episode of the In Vivo podcast features an interview Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies from cord blood, on how they are working across regulatory markets to provide a novel treatment for degenerative diseases.
What this episode covers
The latest episode of the In Vivo podcast features an interview Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies from cord blood, on how they are working across regulatory markets to provide a novel treatment for degenerative diseases.
NOW PLAYING
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m